Latest filing published 15 Apr 2015 for Assembly Biosciences, INC..
No signal scores available.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of David Jonathan Barrett across 3 companies, led by Assembly Biosciences, Inc., Neuro-Hitech, Inc. and Fortress Biotech, Inc. In total, 8 filings cover trades dated from 26 June 2007 to 11 July 2014.
The open-market record is one-sided, with 3 purchases worth €30k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 share grants.
A typical purchase (the median) is worth €3,766. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +17.5%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 15 April 2015 with a share grant in Assembly Biosciences, Inc. The clock since the last published purchase (27 May 2014) now reads 4,533 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations